Aura Biosciences (AURA) Enterprise Value (2020 - 2026)
Aura Biosciences (AURA) posted Enterprise Value of -$84.8 million for Q1 2026, down 42.47% on a QoQ basis from -$59.5 million in Q4 2025, and down 121.82% year-over-year from $388.6 million in Q1 2025.
Aura Biosciences (AURA) Enterprise Value (2020 - 2026) Analysis & Trends
Aura Biosciences' Enterprise Value history runs 7 years deep, the most recent figure standing at -$84.8 million for Q1 2026.
- Quarterly Enterprise Value fell 121.82% year-over-year to -$84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$84.8 million (down 121.82% YoY) and the FY2025 annual result came in at -$59.5 million, down 87.79% from the prior year.
- Enterprise Value was -$84.8 million for Q1 2026 at Aura Biosciences, down from -$59.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$20000.0 in Q4 2022 and bottomed at -$107.4 million in Q2 2025.
- A 5-year average of -$38.5 million and a median of -$38.2 million in 2025 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 99.99% in 2022, while the deepest fall reached 305450.0% in 2022.
- Aura Biosciences' Enterprise Value stood at -$20000.0 in 2022, then sank by 205215.0% to -$41.1 million in 2023, then advanced by 22.82% to -$31.7 million in 2024, then plunged by 87.79% to -$59.5 million in 2025, then tumbled by 42.47% to -$84.8 million in 2026.
- Business Quant data shows AURA's Enterprise Value at -$84.8 million in Q1 2026, -$59.5 million in Q4 2025, and -$47.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -84.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.79 Mn |
| Dec 31, 2025 | -59.52 Mn |
| Sep 30, 2025 | -47.55 Mn |
| Jun 30, 2025 | -107.37 Mn |
| Mar 31, 2025 | -38.23 Mn |
| Dec 31, 2024 | -31.69 Mn |
| Sep 30, 2024 | -25.41 Mn |
| Jun 30, 2024 | -30.08 Mn |
| Mar 31, 2024 | -26.28 Mn |
| Dec 31, 2023 | -41.06 Mn |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -47.73 Mn |
| Mar 31, 2023 | -20,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | -61.11 Mn |
| Jun 30, 2022 | -53.85 Mn |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -149.06 Mn |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -92.20 Mn |